We examined the role of the MAPK pathway (Erk1/2, JNK and p38) as potential downstream signaling MAPK proteins, as we had previously shown these to be implicated in NDV/FMW-induced cytotoxic effects on lung cancer cells [20, 21]. This evidence concerns the gene MAPK3 and lung carcinoma.